US 10,984,563

Application 16/767,669 · Granted Apr 20, 2021

Method of displaying an image on a see-through display

Estimated expiration

December 20, 2037

11y 31d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTEP2017083934: Resource not found (404)
Earliest effective filing
Dec 20, 2017
+ 20 years
Dec 20, 2037
PTA +0d
Dec 20, 2037
No TD
—
Final
Dec 20, 2037

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
May 28, 2020
Earliest effective filing
December 20, 2017
Issue date
April 20, 2021
PTA
0 days
Base expiry (before PTA)
December 20, 2037

December 20, 2017 + 20 years = December 20, 2037

  • National stage entry of application PCTEP2017083934, filed Dec 20, 2017

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 16/767,669 · US 10,984,563

PatentReply compiles the prosecution history behind US 10,984,563: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US10984563

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.